![]() |
市場調查報告書
商品編碼
1452931
全球創傷固定裝置市場 2024-2031Global Trauma Fixation Devices Market 2024-2031 |
預計在預測期內(2024-2031 年),全球創傷固定裝置市場將以 7.4% 的CAGR成長。創傷固定器材市場的重要因素包括退化性骨疾病的增加、創傷固定器材研發投入的增加以及創傷和事故病例的增加。根據英國政府提供的全國統計數據,2022年,共有29,742人死亡或重傷(KSI),登記死亡病例1,711例,各種嚴重程度的傷亡135,480人。因此,英國的外科手術數量正在增加。
全球創傷固定裝置市場按產品類型、材料、應用和最終用戶細分。根據產品類型,市場分為內固定器和外固定器。內固定器包括板和螺絲、桿和銷、電線和電纜、髓內釘和空心螺絲。外固定器包括單側和雙側固定器、圓形固定器和混合固定器。根據材料,市場細分為不銹鋼、鈦和生物可吸收材料。根據應用,市場分為上肢、下肢、脊椎和其他(肋骨固定)。此外,根據最終用戶,市場細分為醫院、門診手術中心和創傷中心。在這些材料中,生物可吸收材料子細分市場預計將佔據相當大的市場佔有率,因為生物可吸收材料在創傷裝置中的採用越來越多,可在體內分解,消除了切除手術的需要並改善了骨科治療的效果。
其中,生物可吸收材料細分市場預計將在全球創傷固定器材市場中佔據相當大的佔有率。該細分市場的成長歸因於切除手術需求的減少以及生物材料技術和監管部門批准的不斷進步。 2023 年 3 月,Bioretec Ltd. 的 RemeOs™ 創傷螺絲獲得 FDA 市場授權,這是一種用於骨折癒合的生物可吸收鎂合金植入物。它的目的是取代傳統的鈦和鋼植入物,消除切除手術的需要,並提高手術效果。 RemeOs(TM) 支持骨科診所的營運目標,並改善踝關節骨折患者的價值主張。
全球創傷固定器材市場根據地理位置進一步細分,包括北美(美國和加拿大)、歐洲(英國、義大利、西班牙、德國、法國和歐洲其他地區)、亞太地區(印度、中國、日本、韓國和亞洲其他地區)以及世界其他地區(中東和非洲以及拉丁美洲)。其中,歐洲預計將在全球市場中佔據顯著佔有率。其中一個重要因素,包括運動相關傷害的激增,增加了創傷固定解決方案的需求。根據美國國立衛生研究院(NIH) 2023 年題為「2021/22 歐洲橄欖球傷害監測報告:超級盃、20 歲以下和18 歲以下錦標賽」的研究,學校和18 歲以下運動員報告每1000 名球員中受傷率低於47 人- 比賽時間約為成年男子國際比賽的一半。
在所有地區中,北美地區預計在預測期內將以相當大的CAGR成長。該區域市場的成長歸因於骨科手術發生率的上升、工業化的不斷發展導致包括工作場所傷害在內的意外傷害發生率的上升,以及骨折和骨科創傷等外傷的發生率不斷上升。根據美國勞工統計局的數據,2022年美國有5,486起致命工傷,比2021年的5,190起增加了5.7%。致命工傷率為每10萬名全職當量工人中有3.7人死亡,到2021 年,每10 萬名全職員工中的3.6 名將增加。由於這些因素,鼓勵主要參與者推出該產品來滿足當前的市場需求。 2023 年 9 月,Orthofix Medical 在美國推出了 Galaxy Fixation Gemini 系統。用於治療下肢和上肢創傷性骨折的穩定外固定系統。
服務於全球創傷固定設備市場的主要公司包括 CONMED Corp.、DePuy Synthes(Johnson & Johnson 公司)、Integra LifeSciences Holdings Corp.、Smith & Nephew Plc 等。市場參與者透過各種策略(包括併購、合作、合作、融資和新產品發布),為市場成長做出了巨大貢獻,以保持市場競爭力。例如,2024 年 1 月,Extremity Medical LLC 與全球醫療保健解決方案公司 Henry Schein, Inc. 合作,擴大其骨科四肢植入系統。此次合作旨在提高全球醫療保健成果。
Global Trauma Fixation Devices Market Size, Share & Trends Analysis Report by Product Type (Internal Fixators and External Fixators), by Material (Stainless Steel, Titanium, and Bioabsorbable Materials), by Applications (Upper Extremities, Lower Extremities, Spine, and Others), and by End-User (Hospitals, Ambulatory Surgical Centers (ASCs), and Trauma Centers) Forecast Period (2024-2031)
The global trauma fixation devices market is anticipated to grow at a CAGR of 7.4% during the forecast period (2024-2031). Significant factors contributing to the trauma fixation devices market include the rising of degenerative bone disorders, increasing investment in R&D of the trauma fixation devices, and increasing number of trauma and accident cases. According to the national statistics provided by the UK government, in 2022, 29,742 people were killed or seriously injured (KSI) casualties, 1,711 fatality cases were registered and 135,480 were casualties of all severities. As a result, the number of surgical procedures is increasing in the UK.
The global trauma fixation devices market is segmented by product type, material, application, and end-user. Based on the product types, the market is sub-segmented into internal fixators and external fixators. Internal fixators include plates and screws, rods and pins, wires and cables, intramedullary nails, and cannulated screws. External fixators include unilateral and bilateral fixators, circular fixators, and hybrid fixators. Based on the materials, the market is sub-segmented into stainless steel, titanium, and bioabsorbable materials. Based on the applications, the market is sub-segmented into upper extremities, lower extremities, spine, and others (rib fixation). Further, based on the end-user, the market is sub-segmented into hospitals, ambulatory surgical centers, and trauma centers. Among the materials, the bioabsorbable material sub-segment is projected to hold a significant share of the market, owing to the rising adoption of bioabsorbable materials in trauma devices degrade in the body, eliminating the need for removal surgeries and improving outcomes in orthopedic treatment.
Among the materials, the bioabsorbable materials sub-segment is expected to hold a considerable share of the global trauma fixation devices market. The segmental growth is attributed to the reduced need for removal surgery, and continuous advancements in biomaterials technology, regulatory approvals. In March 2023, Bioretec Ltd. received FDA market authorization for its RemeOs(TM) trauma screw, a bioresorbable magnesium alloy implant for bone fracture healing. It aimed to replace traditional titanium and steel implants, eliminating the need for removal surgery, and enhancing surgical outcomes. RemeOs(TM) supports operational goals for orthopedic clinics and improves the value proposition for patients with ankle fractures.
The global trauma fixation devices market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Europe is anticipated to hold a prominent share of the market across the globe. One of the significant factors, including a surge in sports-related injuries, boosted the demand for trauma fixation solutions. According to the 2023 National Institutes of Health (NIH) study titled "2021/22 Rugby Europe Injury Surveillance Report: SuperCup, Under-20, and Under-18 Championship," school and under-18 athletes reported injury rates below 47 per 1000 player-match-hours, about half of those in senior adult male international competitions.
Among all regions, the North American region is anticipated to grow at a considerable CAGR over the forecast period. The regional market growth is attributed to the rising incidence of orthopedic surgeries, the increasing industrialization leading to a heightened incidence of unintentional injuries including workplace injuries, and the increasing prevalence of traumatic injuries such as fractures and orthopedic trauma. According to the US Bureau of Labor Statistics, there were 5,486 fatal work injuries recorded in the US in 2022, marking a 5.7% increase from the 5,190 recorded in 2021. The fatal work injury rate was 3.7 fatalities per 100,000 full-time equivalent workers, up from 3.6 per 100,000 full-time equivalents in 2021. Owing to such factors, major key players are encouraged to introduce the product to address the prevailing market demand. In September 2023, Orthofix Medical launched its Galaxy Fixation Gemini system in the US. A stable external fixation system for treating trauma-induced fractures in the lower and upper limbs.
The major companies serving the global trauma fixation devices market include CONMED Corp., DePuy Synthes (a Johnson & Johnson company), Integra LifeSciences Holdings Corp., Smith & Nephew Plc, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in January 2024, Extremity Medical LLC partnered with Henry Schein, Inc., a global healthcare solutions company, expanding its orthopedic extremity implant systems. The collaboration aimed to enhance healthcare outcomes globally.